Position in HRMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,197,314
+$3,206,960 QoQ
Shares Held
362,464
+1.6% QoQ
Ownership
0.622%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#29
of 328 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYCE & ASSOCIATES LP holds $280,073,421 across 31 Biotechnology names. HRMY ranks #7 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
789,745 | $55,795,484 | |
| 2 | INVA |
Innoviva, Inc.
|
1,172,690 | $26,631,789 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
91,041 | $22,284,105 | |
| 4 | CRMD |
CorMedix Inc.
|
2,176,362 | $17,084,441 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
218,487 | $16,272,911 | |
| 6 | ALMS |
Alumis Inc.
|
525,303 | $14,782,026 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
This page
|
362,464 | $13,197,314 | |
| 8 | ZVRA |
Zevra Therapeutics, Inc.
|
882,658 | $12,657,315 |
All Filings in HRMY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,197,314 | 362,464 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,990,354 | 356,671 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $10,409,794 | 278,188 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,253,250 | 81,758 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,575,368 | 81,499 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,713,581 | 81,759 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,813,327 | 81,759 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,148,120 | 78,703 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $2,718,799 | 90,116 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,298,832 | 98,238 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,540,176 | 109,603 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $9,187,036 | 280,349 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $7,726,985 | 219,579 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $10,850,541 | 332,329 | Shares | Sole | 2023-05-23 | |
| 2022-12-31 | $12,687,877 | 230,270 | Shares | Sole | 2023-05-23 | |
| 2022-09-30 | $13,110,282 | 296,010 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $13,079,967 | 268,197 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $12,445,010 | 255,807 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $9,341,741 | 219,084 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $8,792,518 | 229,390 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,614,851 | 128,050 | Shares | Sole | 2021-08-06 | |
| No filing history on record for this holder in this stock. | ||||||